Literature DB >> 33644233

Plateletcrit and Mean Platelet Volume in the Evaluation of Alcoholic Liver Cirrhosis and Nonalcoholic Fatty Liver Disease Patients.

Agata Michalak1, Halina Cichoż-Lach1, Małgorzata Guz2, Joanna Kozicka1, Marek Cybulski2, Witold Jeleniewicz2.   

Abstract

Platelet (PLT) indices have been proposed as potential markers in the assessment of liver fibrosis and exacerbation of liver failure. The aim of our study was to verify mean platelet volume (MPV), platelet distribution width (PDW), and plateletcrit (PCT) in alcohol-related liver cirrhosis (ALC) and nonalcoholic fatty liver disease (NAFLD) patients. One hundred forty-two patients with ALC, 92 with NAFLD, and 68 in control group were enrolled in this study. Hematological indices (MPV, PCT, and PDW) and serological (indirect and direct) markers of liver fibrosis (AAR, APRI, FIB-4, GPR, PICP, PIIINP, TGF-α, PDGF-AB, laminin) were measured in each participant. MELD score in ALC patients and NAFLD fibrosis score (NFS) together with BARD score in the NAFLD group were also obtained. Results were compared between research and control groups. Then, a correlation between evaluated indices was performed in study groups. Receiver operating characteristic curves (ROCs) and area under the curve (AUC) values were applied to assess the diagnostic accuracy of measured indices. Significant increase in PDW and decrease in PCT in comparison to controls were noted in examined ALC (60.4% vs. 51.2% and 0.1% vs. 0.21%, respectively, p < 0.0001) and NAFLD (54.75% vs. 51.2% and 0.19 vs. 0.21%, respectively, p < 0.01) patients. Decreased level of MPV was observed in NAFLD group (7.85 fl vs. 8.90 fl, p < 0.0001). Additionally, PCT correlated with NFS (p < 0.0001). Evaluated PLT indices correlated with MELD score (MPV and PDW, p < 0.001; PCT, p < 0.05). They correlated with indirect and direct markers of liver fibrosis in the whole research group, too. PCT was the parameter with the greatest diagnostic accuracy in ALC patients (AUC = 0,839 for cutoff < 0.17%); in NAFLD group, it was MPV (AUC = 0,808 for cutoff < 7.9 fl). PCT in ALC and MPV in NAFLD can be perceived as potential diagnostic markers.
Copyright © 2021 Agata Michalak et al.

Entities:  

Mesh:

Year:  2021        PMID: 33644233      PMCID: PMC7901043          DOI: 10.1155/2021/8867985

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  40 in total

1.  Mean platelet volume in biopsy-proven non-alcoholic fatty liver disease.

Authors:  Mehmet Celikbilek; Sebnem Gürsoy; Kemal Deniz; Ahmet Karaman; Gökmen Zararsiz; Alper Yurci
Journal:  Platelets       Date:  2012-05-30       Impact factor: 3.862

Review 2.  Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.

Authors:  Agostino Colli; Juan Cristóbal Gana; Jason Yap; Thomasin Adams-Webber; Natalie Rashkovan; Simon C Ling; Giovanni Casazza
Journal:  Cochrane Database Syst Rev       Date:  2017-04-26

Review 3.  Review article: shared disease mechanisms between non-alcoholic fatty liver disease and metabolic syndrome - translating knowledge from systems biology to the bedside.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Aliment Pharmacol Ther       Date:  2019-02-04       Impact factor: 8.171

4.  Neutrophil-lymphocyte ratio and mean platelet volume as predictive factors for liver fibrosis and steatosis in patients with chronic hepatitis B.

Authors:  Agnieszka Pokora Rodak; Sławomir Kiciak; Krzysztof Tomasiewicz
Journal:  Ann Agric Environ Med       Date:  2018-12-04       Impact factor: 1.447

5.  Liaoning Score for Prediction of Esophageal Varices in Cirrhotic Patients Who Had Never Undergone Endoscopy: A Multicenter Cross-Sectional Study in Liaoning Province, China.

Authors:  Xingshun Qi; Yiling Li; Ran Wang; Lianjie Lin; Jing Li; Lijun Wang; Shuang Zheng; Yonghong Sun; Lixin Zhao; Xiaolin Fu; Mengchun Wang; Xinping Qiu; Han Deng; Cen Hong; Qianqian Li; Hongyu Li; Xiaozhong Guo
Journal:  Adv Ther       Date:  2019-05-15       Impact factor: 3.845

6.  High Mean Platelet Volume Is Associated with Worse Outcomes in Patients with HBV-Related Decompensated Cirrhosis.

Authors:  YingChun Ma; WenJia Quan; HuiDi Zhu
Journal:  Ann Clin Lab Sci       Date:  2018-09       Impact factor: 1.256

7.  Plateletcrit: A possible biomarker of inflammation in hepatitis A infection.

Authors:  M E Coskun; A Alidris; M T Temel; S Akbayram; S Hizli
Journal:  Niger J Clin Pract       Date:  2019-05       Impact factor: 0.968

8.  Comparison of platelet number and function between nonalcoholic fatty liver disease and normal individuals.

Authors:  Zeinab Saremi; Mahboobe Rastgoo; Mahyar Mohammadifard; Bita Bijari; Ehsan Akbari
Journal:  J Res Med Sci       Date:  2017-06-21       Impact factor: 1.852

9.  Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume.

Authors:  Robin D Abeles; Benjamin H Mullish; Roberta Forlano; Torben Kimhofer; Maciej Adler; Alexandros Tzallas; Nikolaos Giannakeas; Michael Yee; Jamil Mayet; Robert D Goldin; Mark R Thursz; Pinelopi Manousou
Journal:  Aliment Pharmacol Ther       Date:  2019-03-05       Impact factor: 8.171

10.  Evaluation of Plateletcrit and Platelet Distribution Width in Patients with Non-Alcoholic Fatty Liver Disease: A Retrospective Chart Review Study.

Authors:  Alihan Oral; Tolga Sahin; Fatih Turker; Erdem Kocak
Journal:  Med Sci Monit       Date:  2019-12-23
View more
  3 in total

1.  Early changes in laboratory tests predict liver function damage in patients with moderate coronavirus disease 2019: a retrospective multicenter study.

Authors:  Yiting Wang; Dandan Gao; Xuewen Li; Panyang Xu; Qi Zhou; Junguo Yin; Jiancheng Xu
Journal:  BMC Gastroenterol       Date:  2022-03-09       Impact factor: 3.067

2.  Plateletcrit for predicting prognosis in patients with hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloid.

Authors:  Hongfei Tu; Miao Li; Zhiyuan Chen; Jiamin Zhao; Huali Wang; Jingjing Qian; Cheng Wei; Yang Yang; Yue Zhu; Lingyun Zuo
Journal:  J Clin Lab Anal       Date:  2022-01-16       Impact factor: 2.352

3.  Rethinking Liver Fibrosis Staging in Patients with Hepatocellular Carcinoma: New Insights from a Large Two-Center Cohort Study.

Authors:  Wei Xu; Bolun Li; Zhanwei Yang; Jingdong Li; Fei Liu; Yu Liu
Journal:  J Hepatocell Carcinoma       Date:  2022-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.